Stoic VC logo

Stoic VC

Oceania, New South Wales, Australia, Sydney

Description

Stoic Venture Capital is an early-stage venture fund investing in emerging science and deep technology.

Investor Profile

Stoic VC has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in Australia.
  • Strong thematic focus on Biotechnology, Health Diagnostics, Medical.

Stage Focus

  • Series Unknown (33%)
  • Series A (33%)
  • Series B (33%)

Country Focus

  • Australia (100%)

Industry Focus

  • Biotechnology
  • Health Diagnostics
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Stoic VC frequently co-invest with?

HESTA
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
Uniseed
Oceania, Queensland, Australia, Brisbane
Co-Investments: 3
AustralianSuper
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
Statewide Super
Oceania, South Australia, Australia, Adelaide
Co-Investments: 1
Minderoo Foundation
Oceania, Western Australia, Australia, Perth
Co-Investments: 1
UC
North America, Michigan, United States, Northville
Co-Investments: 1
CSL
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
Hostplus
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
Brandon Capital
Oceania, Victoria, Australia, Melbourne
Co-Investments: 2

Which angels does Stoic VC often collaborate with?

RT
North America, Pennsylvania, United States
Shared Deals: 1

What are some of recent deals done by Stoic VC?

Ena Respiratory

Melbourne, Victoria, Australia

Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.

BiotechnologyHealth DiagnosticsMedical
Series BOct 22, 2025
Amount Raised: $22,400,000
Kinoxis Therapeutics

Melbourne, Victoria, Australia

Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.

BiotechnologyTherapeutics
Series BAug 12, 2024
Amount Raised: $9,548,268
Ena Respiratory

Melbourne, Victoria, Australia

Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.

BiotechnologyHealth DiagnosticsMedical
Series UnknownJun 17, 2021
Amount Raised: $24,181,549
Ena Respiratory

Melbourne, Victoria, Australia

Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.

BiotechnologyHealth DiagnosticsMedical
Series ASep 28, 2020
Amount Raised: $8,299,573